Your Location：
Home >
Browse articles >
Research Progress of Active Components of Traditional Chinese Medicine in Treatment of Hyperlipidemia by Activating PPARα Pathway
Research Progress of Active Components of Traditional Chinese Medicine in Treatment of Hyperlipidemia by Activating PPAR
α Pathway- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 11, Pages: 247-254(2023)
DOI： 10.13422/j.cnki.syfjx.20221903
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 6 )
References
Publication Info
Metrics
344
Views
120
Downloads
3
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanisms and Clinical Research Advances of Curcumin in Modulation of Hyperlipidemia
Hyperlipidemia Animal Models Based on Disease-syndrome Clinical Characteristics of Traditional Chinese and Western Medicine
Traditional Chinese Medicine Intervening Signaling Pathways Related to Type 2 Diabetes Mellitus Complicated with Hyperlipidemia： A Review
Danlianxin Formula Ameliorates Cardiac Dysfunction Associated with Myocardial Infarction in Hyperlipidemic Rats via Epac1/VDAC1/NLRP3/Caspase Signaling Pathway
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Related Author
ZENG Zhijun
LU Wenjie
MA Xiaoxue
JI Yanhua
TONG Yun
LING Siyu
ZENG Yue
LE Chao
Related Institution
School of Sports Health， Jiangxi University of TCM
Shandong Medicine Technician College
Jiangxi Key Laboratory of TCM Etiology Biology
Research Center for Differentiation and Development of Basic Theories of Traditional Chinese Medicine（TCM）， Jiangxi University of TCM
Henan Key Laboratory of Viral Disease Prevention and Treatment of Traditional Chinese Medicine
Chat
